Trial Profile
Effect of sitagliptin monotherapy on serum total ghrelin levels in people with type 2 diabetes.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2011
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 Dec 2011 New trial record
- 01 Nov 2011 Results published in the Diabetes Research and Clinical Practice.